16
Total investments
9
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2025
Avallon automates insurance claims operations with AI agents that handle routine calls and documents processing.
Investor
2024
The open source AI SRE for autonomous incident investigation.
Tracer investigates incidents before they you get pinged, filtering noise, correlating evidence across your stack, and producing an evidence-based RCA for the issues that actually matter.
Tracer is built for SRE and platform engineering teams who are tired of endless loops. With graphs of your workflows, infrastructure, and telemetry, Tracer builds a complete picture of your systems, separating what matters from what doesn’t.
With Tracer, multiple AI agents troubleshoot in parallel, test multiple root-cause hypotheses at once, and start investigating before your team even opens the alert.
Investor
2023
Lindus is an Accountable Research Organization, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, womens health, and diagnostics. Behind each study is an integrated model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.
Investor
Jul 2022
Autonomize AI Agents & Copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Our customers include health plans, providers and life sciences companies.
Unlike generic AI systems retrofitted for healthcare, Autonomize deeply understands medical contexts, terminologies, and operational nuances. Our healthcare-focused AI Agents & Copilots augment knowledge work, drastically reducing administrative burden.
Care management teams spend 78% less time per case, achieving an impressive 85% boost in case review efficiency.
Prior authorization processes that traditionally take 20-30 minutes shrink to mere seconds, accompanied by an 80% reduction in manual errors, saving millions of dollars annually.
Our AI Agents turn chaotic, unstructured healthcare data—clinical notes, PDFs, faxes, and claims—into structured, contextual information that informs decisions and actions. This has driven substantial real-world impact: organizations using Autonomize experience a 92% reduction in manual effort for care gaps and HEDIS chart reviews, dramatically improving compliance and STAR ratings.
Autonomize AI is purpose-built for healthcare, transforming healthcare operations one workflow at a time through AI-native solutions that deliver immediate, scalable impact.
Investor
2022
C8 Health is on a mission to eliminate care inconsistency by bridging the gap between clinical protocols and real-world practice. We combine AI with in-depth expertise in healthcare knowledge management to help hospitals implement their best practices by streamlining access to clinical standards and integrating them into the clinicians workflow, when and where they need them.
Our solutions drive consistent adherence to vetted treatment protocols, empower clinical teams to proactively manage quality outcomes, and improve staff satisfaction. Through our AI-powered platform, including C8 Panda AI, clinicians get instant access to locally vetted, searchable best practices that reduce time spent searching for knowledge while increasing confidence in care delivery.
Trusted by over 100 leading hospitals across the US, including: Mount Sinai, UCSF Health, Brigham & Womens, Metro Health, UTMB, and Dartmouth Health - C8 Health enables healthcare systems to implement their best practices effectively and efficiently, empowering teams and enhancing patient outcomes.
Ready to transform how your hospital implements best practices? Visit c8health.com to learn more
Investor
2022
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies.
Investor
2022
Were a tech company that believes healthcare should feel less like paperwork and more like people. Powered by AI, our platform automates medical practice workflows, from patient journeys to billing to next-generation payments. Backed by €50M in Series B funding from investors like Cathay Innovation, Notion Capital, Lakestar, and b2venture, Nelly is one of the fastest-growing health and fintech companies in Europe.
What we are really proud of: We only work with nice people. We bring together ambitious humans, give them real ownership, and invest in their growth from day one.
If youre looking for a place where your impact is visible and want to work with a great team driven by our Start-Up culture, Nelly is your place to be! Become part of the mission that genuinely transforms European healthcare.
Board Observer
Dec 2021
Our clinical grade voice biomarkers power a health and safety infrastructure layer for all voice communications - actively partnering across telecomms, telehealth, LLM providers, automotive, aviation, defence and more.
Voice is everywhere. We ensure every conversation is safe.
Investor
2020
The logistic industry is affected by intransparencies and inconsistencies along the entire supply chain. Nearly half of all trucks wait on average more than one hour for a usually scheduled offloading at a warehouse due to poor alignment of involved partners. Up to 30% of all trucks in transit run empty due to market intransparencies. We at TradeLink made it our mission to solve intransparencies. Our platform enables frictionless supply chain collaboration within all involved parties. We offer you the solution of nearly all your logistics pain points: no more surprises at the ramp, no more downtime on the yard, no costly and faulty paper processes, no more countless mailings and calls, no more stressed employees.
If you are ready to transform your business now, contact us and shape the future of logistics with TradeLink!
Reach out to us 📥 hello@tradelink.co
Investor
2020
Paid transforms the procure-to-pay process for buyers and their small suppliers, making it easier and faster for them to do business together.
The Paid platform leverages the power of automation allowing buyers to onboard small suppliers in as little as 6 minutes, create and manage work with ease, and offer their suppliers transparent, compliant payment options.
Investor
2020
kencko is a smart food company, reinventing organic fruit and vegetable products to help people eat healthier, and waste less.
Our no-fuss instant smoothies make it easy to add 2.5 servings of fruits and veggies to your daily routine. The only ingredients we use are whole organic plant foods, flash-frozen and slow-dried to retain their fiber and nutrients. Nothing added, nothing taken out except water.
Almost half of the world’s fresh fruits and vegetables are thrown away uneaten. Our process cuts waste by capturing the nutrients of fresh produce in a shelf-stable form, until you’re ready to enjoy them. We also lighten our footprint by using compostable packaging and offsetting all emissions from shipping.
kencko’s smoothies come in a rainbow of flavors to suit your unique nutritional needs. Plus, all members can access free coaching from a registered dietitian to provide the support they need to grow their healthy habits with kencko.
kencko is currently available in the US, Europe, UK, and Singapore.
Angel Investor
2018
Grips empowers retailers and brands to transform competitive intelligence, SKU level insights, and market trends into tangible growth opportunities. By leveraging Grips, businesses can drive higher revenues through identifying untapped market share, discovering new categories, brands, and product opportunities, and unveiling competitor strategies and performance.
With daily data and extensive coverage spanning over 65,000 domains, millions of SKUs, and more than 65,000 brands, Grips provides unparalleled insights that help you uncover blind spots in competitor performance and stay ahead in a competitive market.
Unlock your growth potential with Grips – your partner in strategic market intelligence.
Show all 16 investments ↓
Experience · 21 entries
All (21)
Investments (16)
Board (1)
2025
Investor
2025
Avallon automates insurance claims operations with AI agents that handle routine calls and documents processing.
2024
Investor
2024
The open source AI SRE for autonomous incident investigation.
Tracer investigates incidents before they you get pinged, filtering noise, correlating evidence across your stack, and producing an evidence-based RCA for the issues that actually matter.
Tracer is built for SRE and platform engineering teams who are tired of endless loops. With graphs of your workflows, infrastructure, and telemetry, Tracer builds a complete picture of your systems, separating what matters from what doesn’t.
With Tracer, multiple AI agents troubleshoot in parallel, test multiple root-cause hypotheses at once, and start investigating before your team even opens the alert.
2023
Partner
2023
Loop is building a global ecosystem of founders who are passionate about improving the health of everyone. From speedier clinical trials to better patient experiences, our founders are turning health and bio into data-driven industries.
Investor
2023
Lindus is an Accountable Research Organization, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, womens health, and diagnostics. Behind each study is an integrated model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.
Show all 21 entries ↓
Investment activity
2016–2025 · 16 investments
Recent (last 2 years)Earlier
